최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecules a journal of synthetic chemistry and natural product chemistry, v.26 no.19, 2021년, pp.6077 -
Kim, Jungnam (Department of Chemistry, KAIST, Daejeon 34141, Korea) , Choi, Hyunwoo (wjdska13@kaist.ac.kr (J.K.)) , Kang, Eunhye K. (hwchoi0806@kaist.ac.kr (H.C.)) , Ji, Gil Yong (ehkang@kaist.ac.kr (E.K.K.)) , Kim, Youjeong (Department of Chemistry, KAIST, Daejeon 34141, Korea) , Choi, Insung S. (wjdska13@kaist.ac.kr (J.K.))
(‒)-Cannabidiol (CBD) is one of the major phytocannabinoids extracted from the Cannabis genus. Its non-psychoactiveness and therapeutic potential, partly along with some anecdotal—if not scientific or clinical—evidence on the prevention and treatment of neurological diseases, ha...
1. Reekie T. Scott M. Kassiou M. The evolving science of phytocannabinoids Nat. Rev. Chem. 2018 2 0101 10.1038/s41570-017-0101
2. Campos A.C. Fogaça M.V. Sonego A.B. Guimarães F.S. Cannabidiol, neuroprotection and neuropsychiatric disorders Pharmacol. Res. 2016 112 119 127 10.1016/j.phrs.2016.01.033 26845349
3. Scuderi C. Filippis D.D. Iuvone T. Blasio A. Steardo A. Esposito G. Cannabidiol in medicine: A review of its therapeutic potential in CNS disorders Phytother. Res. 2009 23 597 602 10.1002/ptr.2625 18844286
4. Iuvone T. Esposito G. Filippis D.D. Scuderi C. Steardo L. Cannabidiol: A promising drug for neurodegenerative disorders? CNS Neurosci. Ther. 2009 15 65 75 10.1111/j.1755-5949.2008.00065.x 19228180
5. Elsaid S. Le Foll B. The complexity of pharmacology of cannabidiol (CBD) and its implications in the treatment of brain disorders Neuropsychopharmacology 2020 45 229 230 10.1038/s41386-019-0518-1 31511618
7. Bih C.I. Chen T. Nunn A.V. Bazelot M. Dallas M. Whalley B.J. Molecular targets of cannabidiol in neurological disorders Neurotherapeutics 2015 12 699 730 26264914
8. McGuire P. Robson P. Cubala W.J. Vasile D. Morrison P.D. Barron R. Taylor A. Wright S. Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial Am. J. Psychiatry 2018 175 225 231 10.1176/appi.ajp.2017.17030325 29241357
9. Eisenstein M. From menace to medicine Nature 2019 572 S2 S4 10.1038/d41586-019-02524-5
10. Whiting P.F. Wolff R.F. Deshpande S. Nisio M.D. Duffy S. Hernandez A.V. Keurentjes J.C. Lang S. Misso K. Ryder S. Cannabinoids for medical use: A systematic review and meta-analysis J. Am. Med. Assoc. 2015 313 2456 2473 10.1001/jama.2015.6358
11. Huestis M.A. Solimini R. Pichini S. Pacifici R. Carlier J. Busardò F.P. Cannabidiol adverse effects and toxicity Curr. Neuropharmacol. 2019 17 974 989 10.2174/1570159X17666190603171901 31161980
12. Chesney E. Oliver D. Green A. Sovi S. Wilson J. Englund A. Freeman T.P. McGuire P. Adverse effects of cannabidiol: A systematic review and meta-analysis of randomized clinical trials Neuropsychopharmacol 2020 45 1799 1806 10.1038/s41386-020-0667-2 32268347
13. Millar S.A. Stone N.L. Bellman Z.D. Yates A.S. England T.J. O’Sullivan S.E. A systematic review of cannabidiol dosing in clinical populations Br. J. Clin. Pharmacol. 2019 85 1888 1900 10.1111/bcp.14038 31222854
14. Gould J. The cannabis crop Nature 2015 525 S2 S3 10.1038/525S2a 26398736
15. Vitale R.M. Iannotti F.A. Amodeo P. The (poly)pharmacology of cannabidiol in neurological and neuropsychiatric disorders: Molecular mechanisms and targets Int. J. Mol. Sci. 2021 22 4876 10.3390/ijms22094876 34062987
16. Sonego A.B. Prado D.S. Vale G.T. Sepulveda-Diaz J.E. Cunha T.M. Tirapelli C.R. Del Bel E.A. Raisman-Vozari R. Guimarães F.S. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors Brain Behav. Immun. 2018 74 241 251 10.1016/j.bbi.2018.09.014 30217539
17. Mecha M. Feliú A. Iñigo P.M. Mestre L. Carrillo-Salinas F.J. Guaza C. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors Neurobiol. Dis. 2013 59 141 150 10.1016/j.nbd.2013.06.016 23851307
18. Banker G.A. Goslin K. Types of nerve cell cultures, their advantages and limitations Culturing Nerve Cells 2nd ed. Banker G.A. Goslin K. The MIT Press Cambridge, MA, USA 1998 11 35
19. Kaech S. Banker G. Culturing hippocampal neurons Nat. Protoc. 2006 1 2406 2415 10.1038/nprot.2006.356 17406484
20. Howlett A.C. Blume L.C. Dalton G.D. CB1 cannabinoid receptors and their associated proteins Curr. Med. Chem. 2010 17 1382 1393 10.2174/092986710790980023 20166926
21. Marsicano G. Moosmann B. Hermann H. Lutz B. Behl C. Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1 J. Neurochem. 2002 80 448 456 10.1046/j.0022-3042.2001.00716.x 11905991
22. Kriegstein A.R. Dichter M.A. Morphological classification of rat cortical neurons in cell culture J. Neurosci. 1983 3 1634 1647 10.1523/JNEUROSCI.03-08-01634.1983 6875660
23. Hampson A.J. Grimaldi M. Axelrod J. Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants Proc. Natl. Acad. Sci. USA 1998 95 8268 8273 10.1073/pnas.95.14.8268 9653176
24. Kim J. Choi J.Y. Seo J. Choi I.S. Neuroprotective effect of cannabidiol against hydrogen peroxide in hippocampal neuron culture Cannabis Cannabinoid Res. 2021 6 40 47 10.1089/can.2019.0102 33614951
25. Ryan D. Drysdale A.J. Lafourcade C. Pertwee R.G. Platt B. Cannabidiol targets mitochondria to regulate intracellular Ca 2+ levels J. Neurosci. 2009 29 2053 2063 10.1523/JNEUROSCI.4212-08.2009 19228959
26. Echeverry C. Prunell G. Narbondo C. de Medina V.S. Nadal X. Reyes-Parada M. Scorza C. A comparative in vitro study of the neuroprotective effect induced by cannabidiol, cannabigerol, and their respective acid forms: Relevance of the 5-HT1A receptors Neurotox. Res. 2021 39 335 348 10.1007/s12640-020-00277-y 32886342
27. Sun Y. Dolmetsch R.E. Investigating the therapeutic mechanism of cannabidiol in a human induced pluripotent stem cell (iPSC)-based model of Dravet syndrome. Cold Spring Harb. Symp Quant. Biol. 2018 83 185 191 10.1101/sqb.2018.83.038174 31186344
28. Drysdale A.J. Ryan D. Pertwee R.G. Platt B. Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells Neuropharmacology 2006 50 621 631 10.1016/j.neuropharm.2005.11.008 16386766
29. Ryan D. Drysdale A.J. Pertwee R.G. Platt B. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia Neurosci. Lett. 2006 408 236 241 10.1016/j.neulet.2006.09.008 16997463
30. Ryan D. Drysdale A.J. Pertwee R.G. Platt B. Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue Eur. J. Neurosci. 2007 25 2093 2102 10.1111/j.1460-9568.2007.05448.x 17419758
31. Bouron A. Phyto and endocannabinoids exert complex actions on calcium and zinc signaling in mouse cortical neurons Biochem. Pharmacol. 2018 152 244 251 10.1016/j.bcp.2018.04.003 29630867
32. Moldzio R. Pacher T. Krewenka C. Kranner B. Novak J. Duvigneau J.C. Rausch W.D. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures Phytomedicine 2012 19 819 824 10.1016/j.phymed.2012.04.002 22571976
33. Duvigneau J.C. Trovato A. Müllebner A. Miller I. Krewenka C. Krenn K. Zich W. Moldzio R. Cannabidiol protects dopaminergic neurons in mesencephalic cultures against the complex I inhibitor rotenone via modulation of heme oxygenase activity and bilirubin Antioxidants 2020 9 135 10.3390/antiox9020135 32033040
34. Perry C.J. Finch P. Müller-Taubenberger A. Leung K.Y. Warren E.C. Damstra-Oddy J. Sharma D. Patra P.H. Glyn S. Boberska J. A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models Br. J. Pharmacol. 2020 177 912 928 10.1111/bph.14892 31693171
35. Lima I.V.A. Bellozi P.M.Q. Batista E.M. Vilela L.R. Brandão I.L. Ribeiro F.M. Moraes M.F.D. Moreira F.A. de Oliveira A.C.P. Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway Neuropharmacology 2020 176 108156 10.1016/j.neuropharm.2020.108156 32574650
36. Ledgerwood C.J. Greenwood S.M. Brett R.R. Pratt J.A. Bushell T.J. Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways Br. J. Pharmacol. 2011 162 286 294 10.1111/j.1476-5381.2010.01015.x 20825410
37. Sun Y. Paşca S.P. Portmann T. Goold C. Worringer K.A. Guan W. Chan K.C. Gai H. Vogt D. Chen Y.J. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients Elife 2016 5 e13073 10.7554/eLife.13073 27458797
38. Hill A.J. Jones N.A. Smith I. Hill C.L. Williams C.M. Stephens G.J. Whalley B.J. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se Neurosci. Lett. 2014 566 269 274 10.1016/j.neulet.2014.03.013 24642454
39. Mendis G.D.C. Berecki G. Morrisroe E. Pachernegg S. Li M. Varney M. Osborne P.B. Reid C.A. Halgamuge S. Petrou S. Discovering the pharmacodynamics of conolidine and cannabidiol using a cultured neuronal network based workflow Sci. Rep. 2019 9 121 10.1038/s41598-018-37138-w 30644434
40. Rosenthaler S. Pöhn B. Kolmanz C. Huu C.N. Krewenka C. Huber A. Kranner B. Rausch W.D. Moldzio R. Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures Neurotoxicol. Teratol. 2014 46 49 56 10.1016/j.ntt.2014.09.003 25311884
41. Dirikoc S. Priola S.A. Marella M. Zsürger N. Chabry J. Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity J. Neurosci. 2007 27 9537 9544 10.1523/JNEUROSCI.1942-07.2007 17804615
42. Mato S. Victoria Sánchez-Gómez M. Matute C. Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes Glia 2010 58 1739 1747 10.1002/glia.21044 20645411
43. Barnham K.J. Masters C.L. Bush A.I. Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discov. 2004 3 205 214 10.1038/nrd1330 15031734
44. Pereira D.M. Valentão P. Pereira J.A. Andrade P.B. Phenolics: From chemistry to biology Molecules 2009 14 2202 2211 10.3390/molecules14062202
45. Song J.H. Shin S.H. Wang W. Ross G.M. Involvement of oxidative stress in ascorbate-induced proapoptotic death of PC12 cells Exp. Neurol. 2001 169 425 437 10.1006/exnr.2001.7680 11358456
46. Moosmann B. Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties Proc. Natl. Acad. Sci. USA 1999 96 8867 8872 10.1073/pnas.96.16.8867 10430862
47. Gleichmann M. Mattson M.P. Neuronal calcium homeostasis and dysregulation Antioxid. Redox Signal. 2011 14 1261 1273 10.1089/ars.2010.3386 20626318
48. Zündorf G. Reiser G. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection Antioxid. Redox Signal. 2011 14 1275 1288 10.1089/ars.2010.3359 20615073
49. Grienberger C. Konnerth A. Imaging calcium in neurons Neuron 2012 73 862 885 10.1016/j.neuron.2012.02.011 22405199
50. Brini M. Calì T. Ottolini D. Carafoli E. Neuronal calcium signaling: Function and dysfunction Cell. Mol. Life Sci. 2014 71 2787 2814 10.1007/s00018-013-1550-7 24442513
51. Mattson M.P. Chan S.J. Neuronal and glial calcium signaling in Alzheimer’s disease Cell Calcium 2003 34 385 397 10.1016/S0143-4160(03)00128-3 12909083
52. Szewczyk B. Zinc homeostasis and neurodegenerative disorders Front. Aging Neurosci. 2013 5 33 10.3389/fnagi.2013.00033 23882214
53. Bisogno T. Hanus L. De Petrocellis L. Tchilibon S. Ponde D.E. Brandi I. Moriello A.S. Davis J.B. Mechoulam R. Di Marzo V. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide Br. J. Pharmacol. 2001 134 845 852 10.1038/sj.bjp.0704327 11606325
54. Evans R.M. Scott R.H. Ross R.A. Multiple actions of anandamide on neonatal rat cultured sensory neurones Br. J. Pharmacol. 2004 141 1223 1233 10.1038/sj.bjp.0705723 15023857
55. Movsesyan V.A. Stoica B.A. Yakovlev A.G. Knoblach S.M. Lea IV P.M. Cernak I. Vink R. Faden A.I. Anandamide-induced cell death in primary neuronal cultures: Role of calpain and caspase pathways Cell Death Differ. 2004 11 1121 1132 10.1038/sj.cdd.4401442 15375383
56. Sugiura T. Kodaka T. Kondo S. Tonegawa T. Nakane S. Kishimoto S. Yamashita A. Waku K. 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells Biochem. Biophys. Res. Commun. 1996 229 58 64 10.1006/bbrc.1996.1757 8954083
57. Brady C.M. DasGupta R. Dalton C. Wiseman O.J. Berkley K.J. Fowler C.J. An open-label pilot study of cannabis-based extracts for bladdery function in advanced multiple sclerosis Mult. Scler. 2004 10 425 433 10.1191/1352458504ms1063oa 15327041
58. Whalley B.J. Wilkinson J.D. Williamson E.M. Constanti A. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro Neurosci. Lett. 2004 365 58 63 10.1016/j.neulet.2004.04.044 15234473
59. Federico A. Cardaioli E. Da Pozzo P. Formichi P. Gallus G.N. Rad E. Mitochondria, oxidative stress and neurodegeneration J. Neurol. Sci 2012 322 254 262 10.1016/j.jns.2012.05.030 22669122
60. Takata K. Kitamura Y. Kakimura J. Shibagaki K. Taniguchi T. Gebicke-Haerter P.J. Smith M.A. Perry G. Shimohama S. Possible protective mechanisms of heme oxygenase-1 in the brain Ann. N. Y. Acad. Sci. 2002 977 501 506 10.1111/j.1749-6632.2002.tb04857.x 12480792
61. Colín-González A.L. Orozco-Ibarra M. Chánez-Cárdenas M.E. Rangel-López E. Santamaría A. Pedraza-Chaverri J. Barrera-Oviedo D. Maldonado P.D. Heme oxygenase-1 (HO-1) upregulation delays morphological and oxidative damage induced in an excitotoxic/pro-oxidant model in the rat striatum Neuroscience 2013 231 91 101 10.1016/j.neuroscience.2012.11.031 23201824
62. Perucca E. Cannabinoids in the treatment of epilepsy: Hard evidence at last? J. Epilepsy Res. 2017 7 61 76 10.14581/jer.17012 29344464
63. GW Pharmaceuticals plc and it’s U.S. subsidiary Greenwich Biosciences announce FDA approval of EPIDIOLEX® (cannabidiol) oral solution—the first plant-derived cannabinoid prescription medicine Available online: https://ir.gwpharm.com/news-releases/news-release-details/gw-pharmaceuticals-plc-and-its-us-subsidiary-greenwich (accessed on 25 June 2018)
64. Köhling R. Voltage-gated sodium channels in epilepsy Epilepsia 2002 43 1278 1295 10.1046/j.1528-1157.2002.40501.x 12423377
65. Bianchi M.T. Pathmanathan J. Cash S.S. From ion channels to complex networks: Magic bullet versus magic shotgun approaches to anticonvulsant pharmacotherapy Med. Hypotheses 2009 72 297 305 10.1016/j.mehy.2008.09.049 19046822
66. Schmitz D. Empson R.M. Heinemann U. Serotonin reduces inhibition via 5-HT1A receptors in area CA1 of rat hippocampal slices in vitro J. Neurosci. 1995 15 7217 7225 10.1523/JNEUROSCI.15-11-07217.1995 7472476
67. Wallace M.J. Wiley J.L. Martin B.R. DeLorenzo R.J. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects Eur. J. Pharmacol. 2001 428 51 57 10.1016/S0014-2999(01)01243-2 11779037
68. Rakhshan F. Day T.A. Blakely R.D. Barker E.L. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells J. Pharmacol. Exp. Ther. 2000 292 960 967 10688610
69. Castillo P.E. Younts T.J. Chávez A.E. Hashimotodani Y. Endocannabinoid signaling and synaptic function Neuron 2012 76 70 81 10.1016/j.neuron.2012.09.020 23040807
70. Catterall W.A. Kalume F. Oakley J.C. NaV1.1 channels and epilepsy J. Physiol. 2010 588 1849 1859 10.1113/jphysiol.2010.187484 20194124
71. Yu F.H. Mantegazza M. Westenbroek R.E. Robbins C.A. Kalume F. Burton K.A. Spain W.J. McKnight G.S. Scheuer T. Catterall W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy Nat. Neurosci. 2006 9 1142 1149 10.1038/nn1754 16921370
72. Heneka M.T. Rodríguez J.J. Verkhratsky A. Neuroglia in neurodegeneration Brain Res. Rev. 2010 63 189 211 10.1016/j.brainresrev.2009.11.004 19944719
73. Esposito G. Scuderi C. Valenza M. Togna G.I. Latina V. De Filippis D. Cipriano M. Carratù M.R. Iuvone T. Steardo L. Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement PLoS ONE 2011 6 e28668 10.1371/journal.pone.0028668 22163051
74. Linnerbauer M. Wheeler M.A. Quintana F.J. Astrocyte crosstalk in CNS inflammation Neuron 2020 108 608 622 10.1016/j.neuron.2020.08.012 32898475
75. Martín-Moreno A.M. Reigada D. Ramírez B.G. Mechoulam R. Innamorato N. Cuadrado A. de Ceballos M.L. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer’s disease Mol. Pharmacol. 2011 79 964 973 10.1124/mol.111.071290 21350020
76. Dos-Santos-Pereira M. Guimarães F.S. Del-Bel E. Raisman-Vozari R. Michel P.P. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption Glia 2020 68 561 573 10.1002/glia.23738 31647138
77. Hassan S. Eldeeb K. Millns P.J. Bennett A.J. Alexander S.P. Kendall D.A. Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation Br. J. Pharmacol. 2014 171 2426 2439 10.1111/bph.12615 24641282
78. Wu H.Y. Goble K. Mecha M. Wang C.C. Huang C.H. Guaza C. Jan T.R. Cannabidiol-induced apoptosis in murine microglial cells through lipid raft Glia 2012 60 1182 1190 10.1002/glia.22345 22535572
79. Feliú A. Moreno-Martet M. Mecha M. Carrillo-Salinas F.J. de Lago E. Fernández-Ruiz J. Guaza C. A Sativex( ® ) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis Br. J. Pharmacol. 2015 172 3579 3595 10.1111/bph.13159 25857324
80. von Widdern J.C. Hohmann T. Dehghani F. Abnormal cannabidiol affects production of pro-inflammatory mediators and astrocyte wound closure in primary astrocytic-microglial cocultures Molecules 2020 25 496 10.3390/molecules25030496
81. Mecha M. Torrao A.S. Mestre L. Carrillo-Salinas F.J. Mechoulam R. Guaza C. Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress Cell Death Dis. 2012 3 e331 10.1038/cddis.2012.71 22739983
82. Auzmendi J. Palestro P. Blachman A. Gavernet L. Merelli A. Talevi A. Calabrese G.C. Ramos A.J. Lazarowski A. Cannabidiol (CBD) inhibited Rhodamine-123 efflux in cultured vascular endothelial cells and astrocytes under hypoxic conditions Front. Behav. Neurosci. 2020 14 32 10.3389/fnbeh.2020.00032 32256321
83. Lawson L.J. Perry V.H. Dri P. Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain Neuroscience 1990 39 151 170 10.1016/0306-4522(90)90229-W 2089275
84. Kierdorf K. Prinz M. Microglia in steady state J. Clin. Investig. 2017 127 3201 3209 10.1172/JCI90602 28714861
85. Gehrmann J. Matsumoto Y. Kreutzberg G.W. Microglia: Intrinsic immuneffector cell of the brain Brain Res. Rev. 1995 20 269 287 10.1016/0165-0173(94)00015-H 7550361
86. Perry V. Nicoll J. Holmes C. Microglia in neurodegenerative disease Nat. Rev. Neurol. 2010 6 193 201 10.1038/nrneurol.2010.17 20234358
87. Diz-Chaves Y. Pernía O. Carrero P. Garcia-Segura L.M. Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice J. Neuroinflammation 2012 9 71 10.1186/1742-2094-9-71 22520439
88. Eichhoff G. Brawek B. Garaschuk O. Microglial calcium signal acts as a rapid sensor of single neuron damage in vivo Biochim. Biophys. Acta 2011 1813 1014 1024 10.1016/j.bbamcr.2010.10.018 21056596
89. Walter L. Franklin A. Witting A. Wade C. Xie Y. Kunos G. Mackie K. Stella N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration J. Neurosci. 2003 23 1398 1405 10.1523/JNEUROSCI.23-04-01398.2003 12598628
90. Wu H.Y. Chang A.C. Wang C.C. Kuo F.H. Lee C.Y. Liu D.Z. Jan T.R. Cannabidiol induced a contrasting pro-apoptotic effect of between freshly isolated and precultured human monocytes Toxicol. Appl. Pharmacol. 2010 246 141 147 10.1016/j.taap.2010.05.003 20471992
91. Wu H.Y. Chu R.M. Wang C.C. Lee C.Y. Lin S.H. Jan T.R. Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8 Toxicol. Appl. Pharmacol. 2008 226 260 270 10.1016/j.taap.2007.09.012 17950393
92. Boatright K.M. Salvesen G.S. Mechanisms of caspase activation Curr. Opin. Cell Biol. 2003 15 725 731 10.1016/j.ceb.2003.10.009 14644197
93. Nashar T.O. Williams N.A. Hirst T.R. Cross-linking of cell surface ganglioside GM1 induces the selective apoptosis of mature CD8+ T lymphocytes Int. Immunol. 1996 8 731 736 10.1093/intimm/8.5.731 8671661
94. Zhou J. Shao H. Cox N.R. Baker H.J. Ewald S.J. Gangliosides enhance apoptosis of thymocytes Cell. Immunol. 1998 183 90 98 10.1006/cimm.1998.1247 9606992
95. Gargalovic P. Dory L. Cellular apoptosis is associated with increased caveolin-1 expression in macrophages J. Lipid Res. 2003 44 1622 1632 10.1194/jlr.M300140-JLR200 12777465
96. Banker G.A. Trophic interactions between astroglial cells and hippocampal neurons in culture Science 1980 209 809 810 10.1126/science.7403847 7403847
97. Hamby M.E. Sofroniew M.V. Reactive astrocytes as therapeutic targets for CNS disorders Neurotherapeutics 2010 7 494 506 10.1016/j.nurt.2010.07.003 20880511
98. Bensinger S.J. Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors Nature 2008 454 470 477 10.1038/nature07202 18650918
99. Robb J.L. Hammad N.A. Weightman P.P.G. Chilton J.K. Beall C. Ellacott K.L.J. The metabolic response to inflammation in astrocytes is regulated by nuclear factor-kappa B signaling Glia 2020 68 2246 2263 10.1002/glia.23835 32277522
100. Siebert J.R. Conta Steencken A. Osterhout D.J. Chondroitin sulfate proteoglycans in the nervous system: Inhibitors to repair Biomed. Res. Int. 2014 2014 845323 10.1155/2014/845323 25309928
101. Tognatta R. Miller R.H. Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies Neuropharmacology 2016 110 539 547 10.1016/j.neuropharm.2016.04.026 27108096
102. Ettle B. Schlachetzki J.C.M. Winkler J. Oligodendroglia and myelin in neurodegenerative diseases: More than just bystanders? Mol. Neurobiol. 2016 53 3046 3062 10.1007/s12035-015-9205-3 25966971
103. Liu Y. Zhou J. Oligodendrocytes in neurodegenerative diseases Front. Biol. 2013 8 127 133 10.1007/s11515-013-1260-4
104. Ogata T. Therapeutic strategies for oligodendrocyte-mediated remyelination Adv. Exp. Med. Biol. 2019 1190 265 279 31760650
105. Hong S.J. Dawson T.M. Dawson V.L. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling Trends Pharmacol. Sci. 2004 25 259 264 10.1016/j.tips.2004.03.005 15120492
106. Proud C.G. eIF2 and the control of cell physiology Semin. Cell Dev. Biol. 2005 16 3 12 10.1016/j.semcdb.2004.11.004 15659334
107. Rossi F. Cattaneo E. Neural stem cell therapy for neurological diseases: Dreams and reality Nat. Rev. Neurosci. 2002 3 401 409 10.1038/nrn809 11988779
108. De Filippis L. Binda E. Concise review: Self-renewal in the central nervous system: Neural stem cells from embryo to adult Stem Cells Transl. Med. 2012 1 298 308 10.5966/sctm.2011-0045 23197809
109. Rodrigues R.S. Lourenço D.M. Paulo S.L. Mateus J.M. Ferreira M.F. Mouro F.M. Moreira J.B. Ribeiro F.F. Sebastião A.M. Xapelli S. Cannabinoid actions on neural stem cells: Implications for pathophysiology Molecules 2019 24 1350 10.3390/molecules24071350 30959794
110. Luján M.Á. Valverde O. The pro-neurogenic effects of cannabidiol and its potential therapeutic implications in psychiatric disorders Front. Behav. Neurosci. 2020 14 109 10.3389/fnbeh.2020.00109 32676014
111. Rajan T.S. Giacoppo S. Scionti D. Diomede F. Grassi G. Pollastro F. Piattelli A. Bramanti P. Mazzon E. Trubiani O. Cannabidiol activates neuronal precursor genes in human gingival mesenchymal stromal cells J. Cell. Biochem. 2017 118 1531 1546 10.1002/jcb.25815 27918106
112. Lanza Cariccio V. Scionti D. Raffa A. Iori R. Pollastro F. Diomede F. Bramanti P. Trubiani O. Mazzon E. Treatment of periodontal ligament stem cells with MOR and CBD promotes cell survival and neuronal differentiation via the PI3K/Akt/mTOR pathway Int. J. Mol. Sci. 2018 19 2341 10.3390/ijms19082341
113. Campos A.C. Ortega Z. Palazuelos J. Fogaça M.V. Aguiar D.C. Díaz-Alonso J. Ortega-Gutiérrez S. Vázquez-Villa H. Moreira F.A. Guzmán M. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system Int. J. Neuropsychopharmacol. 2013 16 1407 1419 10.1017/S1461145712001502 23298518
114. Miranda C.C. Barata T. Vaz S.H. Ferreira C. Quintas A. Bekman E.P. hiPSC-based model of prenatal exposure to cannabinoids: Effect on neuronal differentiation Front. Mol. Neurosci. 2020 13 119 10.3389/fnmol.2020.00119 32733202
115. Schiavon A.P. Bonato J.M. Milani H. Guimarães F.S. Weffort de Oliveira R.M. Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice Prog. Neuropsychopharmacol. Biol. Psychiatry 2016 64 27 34 10.1016/j.pnpbp.2015.06.017 26187374
116. Wolf S.A. Bick-Sander A. Fabel K. Leal-Galicia P. Tauber S. Ramirez-Rodriguez G. Müller A. Melnik A. Waltinger T.P. Ullrich O. Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis Cell Commun. Signal. 2010 8 12 10.1186/1478-811X-8-12 20565726
117. Fogaça M.V. Campos A.C. Coelho L.D. Duman R.S. Guimarães F.S. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling Neuropharmacology 2018 135 22 33 10.1016/j.neuropharm.2018.03.001 29510186
118. Liu H. Jia D. Li A. Chau J. He D. Ruan X. Liu F. Li J. He L. Li B. p53 regulates neural stem cell proliferation and differentiation via BMP-Smad1 signaling and Id1 Stem Cells Dev. 2013 22 913 927 10.1089/scd.2012.0370 23199293
119. Waterhouse E.G. An J.J. Orefice L.L. Baydyuk M. Liao G.-Y. Zheng K. Lu B. Xu B. BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission J. Neurosci. 2012 32 14318 14330 10.1523/JNEUROSCI.0709-12.2012 23055503
120. Brunet A. Datta S.R. Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway Cur. Opin. Neurobiol. 2001 11 297 305 10.1016/S0959-4388(00)00211-7
121. Dudek H. Datta S.R. Franke T.F. Birnbaum M.J. Yao R. Cooper G.M. Segal R.A. Kaplan D.R. Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 1997 275 661 665 10.1126/science.275.5300.661 9005851
122. Abranches E. Silva M. Pradier L. Schulz H. Hummel O. Henrique D. Bekman E. Neural differentiation of embryonic stem cells in vitro: A road map to neurogenesis in the embryo PLoS ONE 2009 4 e6286 10.1371/journal.pone.0006286 19621087
123. Macías W. Carlson R. Rajadhyaksha A. Barczak A. Konradi C. Potassium chloride depolarization mediates CREB phosphorylation in striatal neurons in an NMDA receptor-dependent manner Brain Res. 2001 890 222 232 10.1016/S0006-8993(00)03163-2 11164788
124. Wade D.T. Collin C. Stott C. Duncombe P. Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis Mult. Scler. 2010 16 707 714 10.1177/1352458510367462 20558502
125. Mitelpunkt A. Kramer U. Hausman K.M. Zilbershot F.E. Orbach R. Chernuha V. Fattal-Valevski A. Deutsch L. Heffetz D. Sacks H. The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study Epilepsy Behav. 2019 98 233 237 10.1016/j.yebeh.2019.07.007 31394352
126. Atsmon J. Heffetz D. Deutsch L. Deutsch F. Sacks H. Single-dose pharmacokinetics of oral cannabidiol following administration of PTL101: A new formulation based on gelatin matrix pellets technology Clin. Pharmacol. Drug Dev. 2018 7 751 758 10.1002/cpdd.408 29125702
127. Heussler H. Cohen J. Silove N. Tich N. Bonn-Miller M.O. Du W. O’Neill C. Sebree T. A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome J. Neurodev. Disord. 2019 11 16 10.1186/s11689-019-9277-x 31370779
128. Scheffer I. Hulihan J. Messenheimer J. Ali S. Davis S. Gutterman D. Sebree T. Sadleir L. Cannabidiol transdermal gel in children and adolescents with developmental and epileptic encephalopathies: An open-label clinical trial (1631) Neurology 2020 94 1631
129. Jung B. Lee J.K. Kim J. Kang E.K. Han S.Y. Lee H.-Y. Choi I.S. Synthetic strategies for (-)-cannabidiol and its structural analogs Chem. Asian J. 2019 14 3749 3762 10.1002/asia.201901179 31529613
130. Luo X. Reiter M.A. d’Espaux L. Wong J. Denby C.M. Lechner A. Zhang Y. Grzybowski A.T. Harth S. Lin W. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast Nature 2019 567 123 126 10.1038/s41586-019-0978-9 30814733
131. Choi S.H. Kim Y.H. Hebisch M. Sliwinski C. Lee S. D’Avanzo C. Chen H. Hooli B. Asselin C. Muffat J. A three-dimensional human neural cell culture model of Alzheimer’s disease Nature 2014 515 274 278 10.1038/nature13800 25307057
132. Simitzi C. Ranella A. Stratakis E. Controlling the morphology and outgrowth of nerve and neuroglial cells: The effect of surface topography Acta Biomater. 2017 51 21 52 10.1016/j.actbio.2017.01.023 28069509
133. Marcus M. Baranes K. Park M. Choi I.S. Kang K. Shefi O. Interactions of neurons with physical environments Adv. Healthcare Mater. 2017 6 1700267 10.1002/adhm.201700267 28640544
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.